Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-16ABOS144DERRELL PORTER plan to sell securities of ACUMEN PHARMACEUTICALS, INC. under Form 144MEDIUM
DERRELL PORTER filed Form 144 to notify SEC of plan to sell 12800 units of ACUMEN PHARMACEUTICALS, INC. securities around 2026-06-16, with aggregate market value of $29,767.68. The total outstanding units is 72227580.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in pa...
Micro CapBiotechnology
2026-06-16ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 6160 units of Adaptive Biotechnologies Corporation securities around 2026-06-16, with aggregate market value of $106,075.20. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactio...
Mid CapBiotechnology
2026-06-16AURA144Gibney Anthony plan to sell securities of Aura Biosciences, Inc. under Form 144MEDIUM
Gibney Anthony filed Form 144 to notify SEC of plan to sell 12824 units of Aura Biosciences, Inc. securities around 2026-06-16, with aggregate market value of $82,330.08. The total outstanding units is 103386558.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-06-16BLTE144Dr. Hendrick P. Scholl plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Dr. Hendrick P. Scholl filed Form 144 to notify SEC of plan to sell 10000 units of Belite Bio, Inc. securities around 2026-06-16, with aggregate market value of $1,442,400.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology
2026-06-16ONC144JOHN OYLER plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
JOHN OYLER filed Form 144 to notify SEC of plan to sell 3693 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $980,686.49. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months ...
Mega CapBiotechnology
2026-06-16ONC144XIAOBIN WU plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
XIAOBIN WU filed Form 144 to notify SEC of plan to sell 1357 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $361,996.85. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months ...
Mega CapBiotechnology
2026-06-16ONC144LAI WANG plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
LAI WANG filed Form 144 to notify SEC of plan to sell 1169 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $310,235.88. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months in...
Mega CapBiotechnology
Sponsored
2026-06-16ONC144CHAN LEE plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
CHAN LEE filed Form 144 to notify SEC of plan to sell 590 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $156,925.25. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mega CapBiotechnology